Literature DB >> 21535996

Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons.

Nicole Vogelzangs1, Aartjan T F Beekman, Ingrid G Boelhouwer, Stefania Bandinelli, Yuri Milaneschi, Luigi Ferrucci, Brenda W J H Penninx.   

Abstract

OBJECTIVE: Several studies report a cross-sectional association between metabolic syndrome and depression. Possibly, metabolic syndrome promotes onset or chronicity of depression. However, such a longitudinal link has not yet been confirmed. This study examines whether metabolic syndrome or its components are associated with onset and chronicity of depression.
METHOD: Secondary analyses were performed on data from 823 participants (≥ 65 years of age) in the InCHIANTI study, a prospective, population-based cohort study of older persons. From 1998 to 2000, the study sample was randomly selected from the population registry of 2 sites in Italy using a multistage stratified sampling method. Baseline data collection consisted of a home interview and a medical evaluation at the study clinic. Follow-up for each participant occurred after 3 years and 6 years. Metabolic syndrome at baseline was defined as ≥ 3 of the following: abdominal obesity, high triglycerides, low high-density lipoprotein cholesterol, high blood pressure, and high fasting glucose. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression scale (CES-D) at baseline and after 3 and 6 years. Sample characteristics were compared between persons with and without depression at baseline using χ² and t statistics. Logistic regression analyses were conducted separately in persons with and without depression at baseline to test whether metabolic syndrome at baseline could predict onset and chronicity of depression at follow-up.
RESULTS: At baseline, 235 persons had metabolic syndrome, and 168 were depressed (CES-D score ≥ 20). Among persons not depressed at baseline, 26.0% developed depression. Higher waist circumference increased the odds of depression onset (adjusted OR per SD increase = 1.28; 95% CI, 1.05-1.56), but there was no association between other metabolic syndrome components and onset of depression. Among persons depressed at baseline, depression had a chronic character in 69.0% of persons without and 88.5% of persons with metabolic syndrome. Metabolic syndrome was associated with an almost 3-fold increase in the odds of chronicity of depression (adjusted OR = 2.66; 95% CI, 1.01-7.00), with almost every metabolic syndrome component contributing to this association.
CONCLUSION: In late life, waist circumference, but not metabolic syndrome, predicted onset of depression. Depressed persons with metabolic syndrome were more likely to have persistent or recurrent depression. The latter may suggest that depression with metabolic abnormalities, which could be labeled metabolic depression, identifies a chronic subtype of depression. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21535996      PMCID: PMC6232848          DOI: 10.4088/JCP.10m06559

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  49 in total

1.  Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study.

Authors:  Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Giuseppe Paolisso; Alessandro Ble; Josephine M Egan; E Jeffrey Metter; Angela M Abbatecola; Giovanni Zuliani; Carmelinda Ruggiero; Giorgio Valenti; Jack M Guralnik; Luigi Ferrucci
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-09-12       Impact factor: 4.310

2.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

3.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies.

Authors:  Amanda Nicholson; Hannah Kuper; Harry Hemingway
Journal:  Eur Heart J       Date:  2006-11-02       Impact factor: 29.983

Review 4.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

5.  Depression, the metabolic syndrome and cardiovascular risk.

Authors:  Viola Vaccarino; Candace McClure; B Delia Johnson; David S Sheps; Vera Bittner; Thomas Rutledge; Leslee J Shaw; George Sopko; Marian B Olson; David S Krantz; Susmita Parashar; Oscar C Marroquin; C Noel Bairey Merz
Journal:  Psychosom Med       Date:  2007-12-24       Impact factor: 4.312

6.  Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale.

Authors:  G A Fava
Journal:  J Clin Psychol       Date:  1983-03

7.  Associations between anxiety, depression, and the metabolic syndrome.

Authors:  Michael R Skilton; Philippe Moulin; Jean-Louis Terra; Fabrice Bonnet
Journal:  Biol Psychiatry       Date:  2007-06-05       Impact factor: 13.382

8.  Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study.

Authors:  Anne Herva; Pirkko Räsänen; Jouko Miettunen; Markku Timonen; Kristian Läksy; Juha Veijola; Jaana Laitinen; Aimo Ruokonen; Matti Joukamaa
Journal:  Psychosom Med       Date:  2006 Mar-Apr       Impact factor: 4.312

9.  Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study.

Authors:  M Vanhala; J Jokelainen; S Keinänen-Kiukaanniemi; E Kumpusalo; H Koponen
Journal:  Acta Psychiatr Scand       Date:  2008-11-11       Impact factor: 6.392

10.  Depression: an important comorbidity with metabolic syndrome in a general population.

Authors:  James A Dunbar; Prasuna Reddy; Nathalie Davis-Lameloise; Benjamin Philpot; Tiina Laatikainen; Annamari Kilkkinen; Stephen J Bunker; James D Best; Erkki Vartiainen; Sing Kai Lo; Edward D Janus
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 19.112

View more
  31 in total

1.  Depression and risk of type 2 diabetes: the potential role of metabolic factors.

Authors:  N Schmitz; S S Deschênes; R J Burns; K J Smith; A Lesage; I Strychar; R Rabasa-Lhoret; C Freitas; E Graham; P Awadalla; J L Wang
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

Review 2.  The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Authors:  Adriana P Hermida; William M McDonald; Kyle Steenland; Allan Levey
Journal:  Expert Rev Neurother       Date:  2012-11       Impact factor: 4.618

Review 3.  Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders.

Authors:  Rita Barandas; Dominic Landgraf; Michael J McCarthy; David K Welsh
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

4.  Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease?

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Psychosom Med       Date:  2012-01-03       Impact factor: 4.312

5.  Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users.

Authors:  Nicole Vogelzangs; Aartjan T F Beekman; Arianne K B van Reedt Dortland; Robert A Schoevers; Erik J Giltay; Peter de Jonge; Brenda W J H Penninx
Journal:  Neuropsychopharmacology       Date:  2014-01-20       Impact factor: 7.853

6.  Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice.

Authors:  Wenqi Gao; Wei Wang; Jing Zhang; Pengyi Deng; Jun Hu; Jian Yang; Zhifang Deng
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

7.  Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.

Authors:  John S Mulvahill; Ginger E Nicol; David Dixon; Eric J Lenze; Jordan F Karp; Charles F Reynolds; Daniel M Blumberger; Benoit H Mulsant
Journal:  J Am Geriatr Soc       Date:  2017-12       Impact factor: 5.562

8.  Depressive symptom profiles, cardio-metabolic risk and inflammation: Results from the MIDUS study.

Authors:  Diana A Chirinos; Kyle W Murdock; Angie S LeRoy; Christopher Fagundes
Journal:  Psychoneuroendocrinology       Date:  2017-04-29       Impact factor: 4.905

9.  Major depressive disorder and cardiometabolic disease risk among sub-Saharan African adults.

Authors:  Bizu Gelaye; Michelle A Williams; Seblewengel Lemma; Yemane Berhane; Jesse R Fann; Ann Vander Stoep; Xiao-Hua Andrew Zhou
Journal:  Diabetes Metab Syndr       Date:  2014-06-14

10.  Heritability of metabolic syndrome traits in a large population-based sample.

Authors:  Jenny van Dongen; Gonneke Willemsen; Wei-Min Chen; Eco J C de Geus; Dorret I Boomsma
Journal:  J Lipid Res       Date:  2013-08-05       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.